ArticleScientific reports2023

Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer.

Turcin Saridogan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.